Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Glassman

Showing results (221-230 of 229) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 229 results.
JAMA Ophthalmology|October 30, 2015
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical PracticeJeffrey S Heier, Neil M Bressler, Robert L Avery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphomaC H Moskowitz, J R Bertino, J R Glassman, et al.
The New England Journal of Medicine|February 19, 2015
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema, John A Wells, Adam R Glassman, et al.
Ophthalmology|November 25, 2006
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema, David J Browning, Adam R Glassman, et al.
JAMA|November 14, 2015
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial, Jeffrey G Gross, Adam R Glassman, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 11, 2007
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema, Donald S Fong, Samara F Strauber, et al.
The Journal of Primary Prevention|April 28, 2019
Replication of It's Your Game…Keep It Real! in Southeast TexasMelissa F Peskin, Karin K Coyle, Pamela M Anderson, et al.
Nature|September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemnessFei Mo, Zhiya Yu, Peng Li, et al.
Science (New York, N.Y.)|July 20, 2021
Accurate prediction of protein structures and interactions using a three-track neural networkMinkyung Baek, Frank DiMaio, Ivan Anishchenko, et al.
Pageof 23

Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
JAMA Ophthalmology|October 30, 2015
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical PracticeJeffrey S Heier, Neil M Bressler, Robert L Avery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphomaC H Moskowitz, J R Bertino, J R Glassman, et al.
The New England Journal of Medicine|February 19, 2015
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema, John A Wells, Adam R Glassman, et al.
Ophthalmology|November 25, 2006
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema, David J Browning, Adam R Glassman, et al.
JAMA|November 14, 2015
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial, Jeffrey G Gross, Adam R Glassman, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 11, 2007
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema, Donald S Fong, Samara F Strauber, et al.
The Journal of Primary Prevention|April 28, 2019
Replication of It's Your Game…Keep It Real! in Southeast TexasMelissa F Peskin, Karin K Coyle, Pamela M Anderson, et al.
Nature|September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemnessFei Mo, Zhiya Yu, Peng Li, et al.
Science (New York, N.Y.)|July 20, 2021
Accurate prediction of protein structures and interactions using a three-track neural networkMinkyung Baek, Frank DiMaio, Ivan Anishchenko, et al.
Pageof 23